Nearly half of all men and one-third of women in the United States will develop cancer during their lifetime. The mission of the Hippocratic Cancer Research Foundation is to discover, develop and implement effective new treatments for patients with cancer by advancing groundbreaking research. Our goal – to eliminate cancer and save lives – is ambitious but achievable. What is translational cancer research? Sometimes described as a "bench-to-bedside" approach, translational research applies the knowledge gained from basic science research in the laboratory to develop new ways to prevent, diagnose and treat cancer. The Hippocratic Cancer Research Foundation will provide the philanthropic support to fund interdisciplinary research teams at the Robert H. Lurie Comprehensive Cancer Center of Northwestern University, empowering their world-class investigators to join forces and address the most urgent questions in the fields of cancer biology and oncology in daring and innovative ways. By investing in research, with an emphasis on translational cancer research, the HCRF will accelerate and heighten the impact of scientific discoveries. "Cancer can be defeated if physicians, researchers and philanthropists work as a team." - Leonidas Platanias, MD, PhD | Director of the Lurie Cancer Center The Lurie Cancer Center, one of only 49 National Cancer Institute-designated Comprehensive Cancer Centers in the nation, is recognized internationally as a leader in innovative research, state-of-the-art cancer care, training and education for the next generation of clinicians and scientists, and community outreach.